Related references
Note: Only part of the references are listed.Newcastle disease virus degrades SIRT3 via PINK1-PRKN-dependent mitophagy to reprogram energy metabolism in infected cells
Yabin Gong et al.
AUTOPHAGY (2022)
Multiple roles of mothers against decapentaplegic homolog 4 in tumorigenesis, stem cells, drug resistance, and cancer therapy
Chuan-Jing Dai et al.
WORLD JOURNAL OF STEM CELLS (2022)
Cancer statistics in China and United States, 2022: profiles, trends, and determinants
Changfa Xia et al.
CHINESE MEDICAL JOURNAL (2022)
Oncolytic virotherapy: Challenges and solutions
Nasser Hashemi Goradel et al.
CURRENT PROBLEMS IN CANCER (2021)
NDV-D90 inhibits 17β-estradiol-mediated resistance to apoptosis by differentially modulating classic and nonclassic estrogen receptors in breast cancer cells
Peng Shan et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2021)
PD-1 inhibitor combined with apatinib modulate the tumor microenvironment and potentiate anti-tumor effect in mice bearing gastric cancer
Hao Chen et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Lithium chloride functions as Newcastle disease virus-induced ER-stress modulator and confers anti-viral effect
Kamal Shokeen et al.
VIRUS RESEARCH (2021)
Combining vanadyl sulfate with Newcastle disease virus potentiates rapid innate immune-mediated regression with curative potential in murine cancer models
Thomas M. McAusland et al.
MOLECULAR THERAPY-ONCOLYTICS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
HCC surveillance after SVR in patients with F3/F4 fibrosis
George N. Ioannou
JOURNAL OF HEPATOLOGY (2021)
Recent trends in cancer therapy: A review on the current state of gene delivery
Esam Bashir Yahya et al.
LIFE SCIENCES (2021)
Antitumor immunity enhancement through Newcastle viral oncolysate in mice model: A promising method to treat tumors
Amir Sasan Mozaffari Nejad et al.
SAUDI JOURNAL OF BIOLOGICAL SCIENCES (2021)
MicroRNA-204 plays a role as a tumor suppressor in Newcastle disease virus-induced oncolysis in lung cancer A549 cells
Ying Liang et al.
ONCOLOGY LETTERS (2021)
NDV related exosomes enhance NDV replication through exporting NLRX1 mRNA
Xiaohong Xu et al.
VETERINARY MICROBIOLOGY (2021)
Oncolytic Virotherapy Treatment of Breast Cancer: Barriers and Recent Advances
Amy Kwan et al.
VIRUSES-BASEL (2021)
Virotherapy in Germany-Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies
Dirk M. Nettelbeck et al.
VIRUSES-BASEL (2021)
Loss of Smad4 promotes aggressive lung cancer metastasis by de-repression of PAK3 via miRNA regulation
Xiaohong Tan et al.
NATURE COMMUNICATIONS (2021)
Activation of the eIF2α/ATF4 axis drives triple-negative breast cancer radioresistance by promoting glutathione biosynthesis
Xupeng Bai et al.
REDOX BIOLOGY (2021)
Newcastle-disease-virus-induced ferroptosis through nutrient deprivation and ferritinophagy in tumor cells
Xianjin Kan et al.
ISCIENCE (2021)
Advances in the Study of Antitumour Immunotherapy for Newcastle Disease Virus
Qiuxing Meng et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2021)
Oncolytic Newcastle disease virus reduces growth of cervical cancer cell by inducing apoptosis
Mohsen Keshavarz et al.
SAUDI JOURNAL OF BIOLOGICAL SCIENCES (2020)
Radiomics machine-learning signature for diagnosis of hepatocellular carcinoma in cirrhotic patients with indeterminate liver nodules
Fatima-Zohra Mokrane et al.
EUROPEAN RADIOLOGY (2020)
Wnt status-dependent oncogenic role of BCL9 and BCL9L in hepatocellular carcinoma
Nicole Huge et al.
HEPATOLOGY INTERNATIONAL (2020)
PCOS serum-derived exosomal miR-27a-5p stimulates endometrial cancer cells migration and invasion
Xiaoxia Che et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2020)
Targeting aerobic glycolysis by dichloroacetate improves Newcastle disease virus-mediated viro-immunotherapy in hepatocellular carcinoma
Gang Meng et al.
BRITISH JOURNAL OF CANCER (2020)
Oncolytic Newcastle disease virus activation of the innate immune response and priming of antitumor adaptive responses in vitro
Shannon Burke et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Targeting STAT3 enhances NDV-induced immunogenic cell death in prostate cancer cells
Xueke Wang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Intratumoral expression of IL-7 and IL-12 using an oncolytic virus increases systemic sensitivity to immune checkpoint blockade
Shinsuke Nakao et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Recent advances of oncolytic virus in cancer therapy
Moumita Mondal et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)
Computer-aided designing of oncolytic viruses for overcoming translational challenges of cancer immunotherapy
Anjali Lathwal et al.
DRUG DISCOVERY TODAY (2020)
Oncolytic Newcastle disease virus delivered by Mesenchymal stem cells-engineered system enhances the therapeutic effects altering tumor microenvironment
Mohsen Keshavarz et al.
VIROLOGY JOURNAL (2020)
Exploring the Prospects of Engineered Newcastle Disease Virus in Modern Vaccinology
Muhammad Bashir Bello et al.
VIRUSES-BASEL (2020)
Circ-OXCT1 Suppresses Gastric Cancer EMT and Metastasis by Attenuating TGF-β Pathway Through the Circ-OXCT1/miR-136/SMAD4 Axis
Jianjun Liu et al.
ONCOTARGETS AND THERAPY (2020)
Current Strategies and Future Perspectives for Precision Medicine in Pancreatic Cancer
Ivonne Regel et al.
CANCERS (2020)
Newcastle Disease Virus as a Vaccine Vector for 20 Years: A Focus on Maternally Derived Antibody Interference
Zenglei Hu et al.
VACCINES (2020)
Engineering and combining oncolytic measles virus for cancer therapy
Mathias F. Leber et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2020)
Perspective Rational Cancer Treatment Combinations: An Urgent Clinical Need
Julia Boshuizen et al.
MOLECULAR CELL (2020)
Hexokinase inhibition using D-Mannoheptulose enhances oncolytic newcastle disease virus-mediated killing of breast cancer cells
Ahmed Ghdhban Al-Ziaydi et al.
CANCER CELL INTERNATIONAL (2020)
Newcastle Disease virus infection activates PI3K/Akt/mTOR and p38 MAPK/Mnk1 pathways to benefit viral mRNA translation via interaction of the viral NP protein and host eIF4E
Yuan Zhan et al.
PLOS PATHOGENS (2020)
Cancer Metabolism: Phenotype, Signaling and Therapeutic Targets
Jae Hyung Park et al.
CELLS (2020)
Oncolytic effects of the recombinant Newcastle disease virus, rAF-IL12, against colon cancer cells in vitro and in tumor-challenged NCr-Foxe1nu nude mice
Syed Umar Faruq Syed Najmuddin et al.
PEERJ (2020)
Newcastle Disease Virus at the Forefront of Cancer Immunotherapy
Bharat Burman et al.
CANCERS (2020)
Molecular principles of metastasis: a hallmark of cancer revisited
Jawad Fares et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Application of CRISPR-Cas9 for Long Noncoding RNA Genes in Cancer Research
Shuai Zhen et al.
HUMAN GENE THERAPY (2019)
Perspectives on immunotherapy via oncolytic viruses
Alberto Reale et al.
INFECTIOUS AGENTS AND CANCER (2019)
Fludarabine as an Adjuvant Improves Newcastle Disease Virus-Mediated Antitumor Immunity in Hepatocellular Carcinoma
Gang Meng et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
Regression of solid breast tumours in mice by Newcastle disease virus is associated with production of apoptosis related-cytokines
Juraimi Raihan et al.
BMC CANCER (2019)
Adaptation of the Newcastle Disease Virus to Cell Cultures for Enhancing Its Oncolytic Properties
K. S. Yurchenko et al.
ACTA NATURAE (2019)
STAT3 Contributes To Oncolytic Newcastle Disease Virus-Induced Immunogenic Cell Death in Melanoma Cells
Xiaoyan Shao et al.
FRONTIERS IN ONCOLOGY (2019)
Trends in modes of death in heart failure over the last two decades: less sudden death but cancer deaths on the rise
Pedro Moliner et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
Optimizing oncolytic virotherapy in cancer treatment
Kevin Harrington et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
LaSota Strain Expressing The Rabies Virus Glycoprotein (rL-RVG) Suppresses Gastric Cancer by Inhibiting the Alpha 7 Nicotinic Acetylcholine Receptor (α7 nAChR)/Phosphoinositide 3-Kinase (PI3K)/AKT Pathway
Xuefeng Bu et al.
MEDICAL SCIENCE MONITOR (2019)
Final analyses of OPTiM: a randomized phase III trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in unresectable stage III- IV melanoma
Robert H. Andtbacka et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
MicroRNA-598 inhibits the growth and maintenance of gastric cancer stem-like cells by down-regulating RRS1
Yanling Ma et al.
CELL CYCLE (2019)
Application of Newcastle disease virus in the treatment of colorectal cancer
Hui Song et al.
WORLD JOURNAL OF CLINICAL CASES (2019)
Migration of gastric cancer is suppressed by recombinant Newcastle disease virus (rL-RVG) via regulating α7-nicotinic acetylcholine receptors/ERK- EMT
Xuefeng Bu et al.
BMC CANCER (2019)
eIF2α-CHOP-BCl-2/JNK and IRE1α-XBP1/JNK signaling promote apoptosis and inflammation and support the proliferation of Newcastle disease virus
Yanrong Li et al.
CELL DEATH & DISEASE (2019)
Evaluation of a Recombinant Newcastle Disease Virus Expressing Human IL12 against Human Breast Cancer
Zahiah Mohamed Amin et al.
SCIENTIFIC REPORTS (2019)
Discovery of HSPG2 (Perlecan) as a Therapeutic Target in Triple Negative Breast Cancer
Stephen Kalscheuer et al.
SCIENTIFIC REPORTS (2019)
Antiviral interferons induced by Newcastle disease virus (NDV) drive a tumor-selective apoptosis
Teridah Ernala Ginting et al.
SCIENTIFIC REPORTS (2019)
Immunotherapy for gastric cancer: dilemmas and prospect
Qingfang Zhao et al.
BRIEFINGS IN FUNCTIONAL GENOMICS (2019)
2-Deoxyglucose and Newcastle Disease Virus Synergize to Kill Breast Cancer Cells by Inhibition of Glycolysis Pathway Through Glyceraldehyde3-Phosphate Downregulation
Ahmed Majeed Al-Shammari et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2019)
Tumour heterogeneity and resistance to cancer therapies
Ibiayi Dagogo-Jack et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Viral strategies for triggering and manipulating mitophagy
Linliang Zhang et al.
AUTOPHAGY (2018)
Human Papilloma Virus and Autophagy
Domenico Mattoscio et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Oncolytic Virus Combination Therapy: Killing One Bird with Two Stones
Nikolas Tim Martin et al.
MOLECULAR THERAPY (2018)
Pre-existing Immunity to Oncolytic Virus Potentiates Its Immunotherapeutic Efficacy
Jacob M. Ricca et al.
MOLECULAR THERAPY (2018)
IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor
Keishi Adachi et al.
NATURE BIOTECHNOLOGY (2018)
Newcastle Disease Virus Infection in Quail
Leonardo Susta et al.
VETERINARY PATHOLOGY (2018)
Dendritic cells loaded with the lysate of tumor cells infected with Newcastle Disease Virus trigger potent anti-tumor immunity by promoting the secretion of IFN-γ and IL-2 from T cells
Lianjing Zhao et al.
ONCOLOGY LETTERS (2018)
Newcastle disease virus enhances the growth-inhibiting and proapoptotic effects of temozolomide on glioblastoma cells in vitro and in vivo
Yang Bai et al.
SCIENTIFIC REPORTS (2018)
Recombinant Newcastle disease virus expressing human IFN-λ1 (rL-hIFN-λ1)-induced apoptosis of A549 cells is connected to endoplasmic reticulum stress pathways
Yulan Yan et al.
THORACIC CANCER (2018)
Role of autophagy in tumorigenesis, metastasis, targeted therapy and drug resistance of hepatocellular carcinoma
Fang Huang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Oncolytic virus immunotherapy: future prospects for oncology
Junaid Raja et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Mammalian MSC from selected species: Features and applications
Christiane Uder et al.
CYTOMETRY PART A (2018)
Overview of Breast Cancer Therapy
Tracy-Ann Moo et al.
PET CLINICS (2018)
Avian Paramyxovirus: A Brief Review
P. Gogoi et al.
TRANSBOUNDARY AND EMERGING DISEASES (2017)
Recombinant Newcastle disease virus expressing human TRAIL as a potential candidate for hepatoma therapy
Yunzhou Wu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Oncolytic potency and reduced virus tumor-specificity in oncolytic virotherapy. A mathematical modelling approach
Khaphetsi Joseph Mahasa et al.
PLOS ONE (2017)
Quantification and phenotypic characterisation of peripheral IFN-γ producing leucocytes in chickens vaccinated against Newcastle disease
S. H. Andersen et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2017)
Circular RNA hsa_circ_0000745 may serve as a diagnostic marker for gastric cancer
Mei Huang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
RIP1 is a central signaling protein in regulation of TNF-α/TRAIL mediated apoptosis and necroptosis during Newcastle disease virus infection
Ying Liao et al.
ONCOTARGET (2017)
NDV-D90 suppresses growth of gastric cancer and cancer-related vascularization
Hong Sui et al.
ONCOTARGET (2017)
Oncolytic Viruses in Cancer Treatment A Review
Sean E. Lawler et al.
JAMA ONCOLOGY (2017)
Oncolytic viral Therapy for Mesothelioma
Daniel F. Pease et al.
FRONTIERS IN ONCOLOGY (2017)
Gastrointestinal stromal tumors (GIST): Facing cell death between autophagy and apoptosis
Gloria Ravegnini et al.
AUTOPHAGY (2017)
Newcastle Disease Virus Vectored Bivalent Vaccine against Virulent Infectious Bursal Disease and Newcastle Disease of Chickens
Sohini Dey et al.
VACCINES (2017)
Evaluation of the oncolytic potential of R2B Mukteshwar vaccine strain of Newcastle disease virus (NDV) in a colon cancer cell line (SW-620)
Kishan K. Sharma et al.
ARCHIVES OF VIROLOGY (2017)
w09, a novel autophagy enhancer, induces autophagy-dependent cell apoptosis via activation of the EGFR-mediated RAS-RAF1-MAP2K-MAPK1/3 pathway
Pinghu Zhang et al.
AUTOPHAGY (2017)
Rescue of recombinant Newcastle disease virus: a short history of how it all started
Aidin Molouki et al.
ARCHIVES OF VIROLOGY (2017)
Proinflammatory response induced by Newcastle disease virus in tumor and normal cells
Teridah Ernala Ginting et al.
ONCOLYTIC VIROTHERAPY (2017)
Opportunities and challenges in combination gene cancer therapy
Kent L. Nastiuk et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Absence of autophagy promotes apoptosis by modulating the ROS-dependent RLR signaling pathway in classical swine fever virus-infected cells
Jingjing Pei et al.
AUTOPHAGY (2016)
Experimental infection with Brazilian Newcastle disease virus strain in pigeons and chickens
Adriano de Oliveira Torres Carrasco et al.
BRAZILIAN JOURNAL OF MICROBIOLOGY (2016)
Current Challenges in Cancer Treatment
Jon Zugazagoitia et al.
CLINICAL THERAPEUTICS (2016)
Temporal, geographic, and host distribution of avian paramyxovirus 1 (Newcastle disease virus)
Kiril M. Dimitrov et al.
INFECTION GENETICS AND EVOLUTION (2016)
Recombinant Newcastle disease virus (NDV/Anh-IL-2) expressing human IL-2 as a potential candidate for suppresses growth of hepatoma therapy
Yunzhou Wu et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2016)
Genetically engineered Newcastle disease virus expressing human interferon-1 induces apoptosis in gastric adenocarcinoma cells and modulates the Th1/Th2 immune response
Xuefeng Bu et al.
ONCOLOGY REPORTS (2016)
Therapeutic targeting of liver cancer with a recombinant DNA vaccine containing the hemagglutinin-neuraminidase gene of Newcastle disease virus via apoptotic-dependent pathways
Li-Gang Chen et al.
ONCOLOGY LETTERS (2016)
Non-tumor tissue derived interleukin-17B activates IL-17RB/AKT/β-catenin pathway to enhance the stemness of gastric cancer
Qingli Bie et al.
SCIENTIFIC REPORTS (2016)
Newcastle disease virus NP and P proteins induce autophagy via the endoplasmic reticulum stress-related unfolded protein response
Jing-Hua Cheng et al.
SCIENTIFIC REPORTS (2016)
Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL
Gila Kazimirsky et al.
STEM CELL RESEARCH & THERAPY (2016)
Newcastle Disease Virus V Protein Targets Phosphorylated STAT1 to Block IFN-I Signaling
Xusheng Qiu et al.
PLOS ONE (2016)
Recombinant Newcastle disease virus expressing P53 demonstrates promising antitumor efficiency in hepatoma model
Ying An et al.
JOURNAL OF BIOMEDICAL SCIENCE (2016)
Oncolytic Newcastle disease virus expressing chimeric antibody enhanced anti-tumor efficacy in orthotopic hepatoma-bearing mice
Ding Wei et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
Tumor-Infiltrating Immune Cells Are Associated With Prognosis of Gastric Cancer
Kai Liu et al.
MEDICINE (2015)
Apoptosis, autophagy, necroptosis, and cancer metastasis
Zhenyi Su et al.
MOLECULAR CANCER (2015)
The therapeutic effect of death: Newcastle disease virus and its antitumor potential
Sara Cuadrado-Castano et al.
VIRUS RESEARCH (2015)
Human renal carcinoma cells respond to Newcastle disease virus infection through activation of the p38 MAPK/NF-κB/IκBα pathway
Wei-Choong Ch'ng et al.
CELLULAR ONCOLOGY (2015)
Identification and Characterization of MEDI4736, an Antagonistic Anti-PD-L1 Monoclonal Antibody
Ross Stewart et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Strategies and Advancements in Harnessing the Immune System for Gastric Cancer Immunotherapy
Vinod Vijay Subhash et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death
Carolien A. Koks et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Strong T-cell costimulation can reactivate tumor antigen-specific T cells in late-stage metastasized colorectal carcinoma patients: Results from a phase I clinical study
Volker Schirrmacher et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Apoptotic induction of lung adenocarcinoma A549 cells infected by recombinant RVG Newcastle disease virus (rL-RVG) in vitro
Yulan Yan et al.
MOLECULAR MEDICINE REPORTS (2015)
Entry of Newcastle Disease Virus into the host cell: Role of acidic pH and endocytosis
Lorena Sanchez-Felipe et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2014)
Genetically engineered Newcastle disease virus expressing interleukin-2 and TNF-related apoptosis-inducing ligand for cancer therapy
Fu-Liang Bai et al.
CANCER BIOLOGY & THERAPY (2014)
Different responses of human pancreatic adenocarcinoma cell lines to oncolytic Newcastle disease virus infection
P. R. A. Buijs et al.
CANCER GENE THERAPY (2014)
Genotype Characterization of Commonly Used Newcastle Disease Virus Vaccine Strains of India
Sohini Dey et al.
PLOS ONE (2014)
Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
Dmitriy Zamarin et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Recombinant Newcastle Disease virus Anhinga Strain (NDV/Anh-EGFP) for Hepatoma Therapy
Yunzhou Wu et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2014)
ISG12a mediates cell response to Newcastle disease viral infection
Nianli Liu et al.
VIROLOGY (2014)
Newcastle disease virus: Current status and our understanding
Ketan Ganar et al.
VIRUS RESEARCH (2014)
Effect of recombinant Newcastle disease virus transfection on lung adenocarcinoma A549 cells in vivo
Yulan Yan et al.
ONCOLOGY LETTERS (2014)
Mitophagy promotes replication of oncolytic Newcastle disease virus by blocking intrinsic apoptosis in lung cancer cells
Gang Meng et al.
ONCOTARGET (2014)
Newcastle Disease Virus Interaction in Targeted Therapy against Proliferation and Invasion Pathways of Glioblastoma Multiforme
Jafri Malin Abdullah et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Multimodal cancer therapy involving oncolytic Newcastle disease virus, autologous immune cells and bi-specific antibodies
Volker Schirrmacher et al.
FRONTIERS IN ONCOLOGY (2014)
TRAIL is Involved in the Tumoricidal Activity of Mouse Natural Killer Cells Stimulated by Newcastle Disease Virus in Vitro
De-Zhi Song et al.
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2013)
Immune responses of poultry to Newcastle disease virus
Darrell R. Kapczynski et al.
DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY (2013)
Newcastle disease virus Malaysian strain AF2240 induces apoptosis in MCF-7 human breast carcinoma cells at an early stage of the virus life cycle
Mohamed Ghrici et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2013)
The Oncolytic Activity of Newcastle Disease Virus in Clear Cell Renal Carcinoma Cells in Normoxic and Hypoxic Conditions: The Interplay Between von Hippel-Lindau and Interferon-β Signaling
Wei-Choong Ch'ng et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2013)
Prostate-Specific Antigen-Retargeted Recombinant Newcastle Disease Virus for Prostate Cancer Virotherapy
Raghunath Shobana et al.
JOURNAL OF VIROLOGY (2013)
Tumour heterogeneity and cancer cell plasticity
Corbin E. Meacham et al.
NATURE (2013)
Uncovering a novel mechanism whereby NK cells interfere with glioblastoma virotherapy
Christopher A. Alvarez-Breckenridge et al.
ONCOIMMUNOLOGY (2013)
Sequencing and analysis of the complete genome of Newcastle disease virus isolated from a commercial poultry farm in 2010
Muhammad Munir et al.
ARCHIVES OF VIROLOGY (2012)
Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions
Dmitriy Zamarin et al.
FUTURE MICROBIOLOGY (2012)
Generation by Reverse Genetics of an Effective, Stable, Live-Attenuated Newcastle Disease Virus Vaccine Based on a Currently Circulating, Highly Virulent Indonesian Strain
Sa Xiao et al.
PLOS ONE (2012)
MicroRNA 421 suppresses DPC4/Smad4 in pancreatic cancer
Jun Hao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Safety and Clinical Usage of Newcastle Disease Virus in Cancer Therapy
Han Yuen Lam et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells
Mercedes B. Fuertes et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Oncolytic Specificity of Newcastle Disease Virus Is Mediated by Selectivity for Apoptosis-Resistant Cells
Mena Mansour et al.
JOURNAL OF VIROLOGY (2011)
Antiproliferative Effect of Newcastle Disease Virus Strain D90 on Human Lung Cancer Cell Line A549
Fang Fu et al.
ONCOLOGY RESEARCH (2011)
Detection of Free Peritoneal Cancer Cells in Gastric Cancer Using Cancer-Specific Newcastle Disease Virus
Joyce Wong et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2010)
Antitumor efficacy of viral therapy using genetically engineered Newcastle disease virus [NDV(F3aa)-GFP] for peritoneally disseminated gastric cancer
Kyo Young Song et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2010)
Type I Interferon-Sensitive Recombinant Newcastle Disease Virus for Oncolytic Virotherapy
Subbiah Elankumaran et al.
JOURNAL OF VIROLOGY (2010)
Engineered Newcastle Disease Virus as an Improved Oncolytic Agent Against Hepatocellular Carcinoma
Jennifer Altomonte et al.
MOLECULAR THERAPY (2010)
The interferon antagonistic activities of the V proteins from two strains of Newcastle disease virus correlate with their known virulence properties
Judith G. Alamares et al.
VIRUS RESEARCH (2010)
Expression of RIG-I, IRF3, IFN-beta and IRF7 determines resistance or susceptibility of cells to infection by Newcastle Disease Virus
Holger Wilden et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2009)
The Nuclear Factor NF-κB Pathway in Inflammation
Toby Lawrence
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2009)
Selective oncolytic effect of an attenuated Newcastle disease virus (NDV-HUJ) in lung tumors
B. Yaacov et al.
CANCER GENE THERAPY (2008)
Recombinant Newcastle disease virus expressing human interleukin-2 serves as a potential candidate for tumor therapy
Heng Zhao et al.
VIRUS RESEARCH (2008)
Tumor selective replication of Newcastle Disease Virus: Association with defects of tumor cells in antiviral defence
Christoph Fiola et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme
AI Freeman et al.
MOLECULAR THERAPY (2006)
Application of autologous tumor cell vaccine and NDV vaccine in treatment of tumors of digestive traet
W Liang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2003)
ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties
BL Liu et al.
GENE THERAPY (2003)
Newcastle disease virus: macromolecules and opportunities
K Yusoff et al.
AVIAN PATHOLOGY (2001)
Cellular responses to DNA damage
CJ Norbury et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)
Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus
DF Stojdl et al.
NATURE MEDICINE (2000)
Share Paper
